Report : A-Z CDF items in Formulary 17/07/2019 07:52:30

[Back]

Section Status CDF Name 08.01.05 Formulary Atezolizumab injection urothelial cancer indications 08.01.05 Formulary Avelumab injection   08.01.05 Formulary Axicabtagene ciloleucel cells dispersion for infusion  08.01.01 Formulary Bendamustine injection  08.01.05 Formulary Bevacizumab injection  08.01.05 Formulary Bortezomib injection  08.01.05 Formulary Brentuximab injection  08.02.04 Formulary Daratumumab injection  08.01.05 Formulary Ibrutinib caps  08.02.04 Formulary Ixazomib caps  08.01.05 Formulary Niraparib caps  08.01.05 Formulary Nivolumab injection skin, head and neck and renal cancers 08.01.05 Formulary Nivolumab injection lung and urothelial cancer 08.02.03 Formulary Obinutuzumab injection  08.01.05 Formulary Olaratumab injection  08.01.05 Formulary Osimertinib tabs  08.01.05 Formulary Pembrolizumab injection lung cancer indications 08.01.05 Formulary Pembrolizumab injection urothelial cancer indications 08.01.05 Formulary Pembrolizumab injection Hodgkin lymphoma 08.01.05 Formulary Tisagenlecleucel cells dispersion for infusion  08.01.01 Formulary Venetoclax tabs

South East London Joint Medicines Formulary